Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for EnBio Holdings, Inc (6092.T), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
11.33
P/B ratioShare price divided by book value per share.
0.66
P/S ratioMarket value divided by annual revenue.
0.48
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
30.81%
Operating marginRevenue left after operating costs.
15.59%
Net marginRevenue left after every cost, including tax and interest.
4.25%
Return on equityProfit as a percentage of shareholders’ equity.
5.75%
Return on assetsProfit as a percentage of total assets.
5.56%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
2.73
Quick ratioThe same, excluding inventory.
1.34
Debt to equityTotal borrowings against shareholders’ equity.
1.09
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$68.31
Book value per shareShareholders’ equity divided by shares outstanding.
$1167.09
Shares outstandingShares currently issued.
8,117,595
Market capitalisationShare price times shares outstanding.
$6.28B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
113
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
3.11%
Payout ratioShare of profit paid out as dividends.